164 related articles for article (PubMed ID: 9390111)
1. Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit.
Appel S; Kumle A; Meier R
Clin Pharmacol Ther; 1997 Nov; 62(5):546-55. PubMed ID: 9390111
[TBL] [Abstract][Full Text] [Related]
2. SDZ HTF 919 stimulates canine colonic motility and transit in vivo.
Nguyen A; Camilleri M; Kost LJ; Metzger A; Sarr MG; Hanson RB; Fett SL; Zinsmeister AR
J Pharmacol Exp Ther; 1997 Mar; 280(3):1270-6. PubMed ID: 9067313
[TBL] [Abstract][Full Text] [Related]
3. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
Castillejo G; Bulló M; Anguera A; Escribano J; Salas-Salvadó J
Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
[TBL] [Abstract][Full Text] [Related]
4. First pharmacokinetic-pharmacodynamic study in humans with a selective 5-hydroxytryptamine4 receptor agonist.
Appel S; Kumle A; Hubert M; Duvauchelle T
J Clin Pharmacol; 1997 Mar; 37(3):229-37. PubMed ID: 9089425
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
6. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395
[TBL] [Abstract][Full Text] [Related]
7. Effect of tegaserod on gut transit in male and female subjects.
Degen L; Petrig C; Studer D; Schroller S; Beglinger C
Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
[TBL] [Abstract][Full Text] [Related]
8. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans.
Manabe N; Camilleri M; Rao A; Wong BS; Burton D; Busciglio I; Zinsmeister AR; Haruma K
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G970-5. PubMed ID: 20378829
[TBL] [Abstract][Full Text] [Related]
9. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
[TBL] [Abstract][Full Text] [Related]
10. Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT4 receptor agonist.
Campbell-Dittmeyer K; Hicks GA; Earnest DL; Greenwood-Van Meerveld B
Neurogastroenterol Motil; 2009 Nov; 21(11):1197-e108. PubMed ID: 19210632
[TBL] [Abstract][Full Text] [Related]
11. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
14. Measuring colonic transit time in chronic idiophatic constipation.
Husni-Hag-Ali R; Gómez Rodríguez BJ; Mendoza Olivares FJ; García Montes JM; Sáchez-Gey Venegas S; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2003 Mar; 95(3):186-90, 181-5. PubMed ID: 12760708
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophin-3 improves functional constipation.
Parkman HP; Rao SS; Reynolds JC; Schiller LR; Wald A; Miner PB; Lembo AJ; Gordon JM; Drossman DA; Waltzman L; Stambler N; Cedarbaum JM;
Am J Gastroenterol; 2003 Jun; 98(6):1338-47. PubMed ID: 12818279
[TBL] [Abstract][Full Text] [Related]
16. The effect of a polymeric enteral formula supplemented with a mixture of six fibres on normal human bowel function and colonic motility.
Silk DB; Walters ER; Duncan HD; Green CJ
Clin Nutr; 2001 Feb; 20(1):49-58. PubMed ID: 11161544
[TBL] [Abstract][Full Text] [Related]
17. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies.
Quigley EM; Wald A; Fidelholtz J; Boivin M; Pecher E; Earnest D
Clin Gastroenterol Hepatol; 2006 May; 4(5):605-13. PubMed ID: 16678076
[TBL] [Abstract][Full Text] [Related]
19. The influence of arginine-vasopressin on stool output and gastrointestinal transit time in healthy volunteers.
Voderholzer WA; Klauser AG; Mühldorfer BE; Fiedler F; Müller-Lissner SA
Z Gastroenterol; 1995 Apr; 33(4):189-92. PubMed ID: 7793116
[TBL] [Abstract][Full Text] [Related]
20. Effect of yacon (Smallanthus sonchifolius) on colonic transit time in healthy volunteers.
Geyer M; Manrique I; Degen L; Beglinger C
Digestion; 2008; 78(1):30-3. PubMed ID: 18781073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
